Cleared Traditional

K090481 - DEMASQ IMAGING SPFTWARE DEVICE

K090481 is an FDA 510(k) clearance for DEMASQ IMAGING SPFTWARE DEVICE, manufactured by Demasq Limited. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 23-day FDA review.

K090481 · Demasq Limited · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Mar 2009
Decision
23d
Days
Class 2
Risk

K090481 is an FDA 510(k) clearance for the DEMASQ IMAGING SPFTWARE DEVICE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Demasq Limited (Cardiff Wales, GB). The FDA issued a Cleared decision on March 19, 2009 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K090481

510(k) Number K090481 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 24, 2009
Decision Date March 19, 2009
Days to Decision 23 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
84d faster than avg
Panel avg: 107d · This submission: 23d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Underwriters Laboratories, Inc.
JEFF RONGERO

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2270
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K090481.
ICAD BREAST INTERVENTIONAL PLANNING SOFTWARE, MODEL D70024
K090223 · Icad, Inc. · Mar 2009
VRAD PICTURE ARCHIVING AND COMMUNICATIONS SYSTEM SOFTWARE
K090649 · Virtual Radiologic Corporation · Mar 2009
BRIT PACS SYSTEMS
K081168 · Brit Systems, Inc. · Mar 2009
UROCARE
K090552 · Neusoft Medical Systems Co., Ltd. · Mar 2009
LUNGPOINT VIRTUAL BRONCHOSCOPIC NAVIGATION VBN SYSTEM
K090095 · Broncus Technologies, Inc. · Mar 2009
DATACOM DC PACS
K083182 · Datacom Technology Corp. · Mar 2009
K090481 · DEMASQ IMAGING SPFTWARE DEVICE
Download PDF FDA Summary Demasq Limited